LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1998 | 06-1998 | 03-1998 | 12-1997 | 09-1997 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,090 | 15,700 | 15,980 | 11,990 | 12,310 |
| Marketable Securities | 6,900 | 6,900 | 8,590 | 14,970 | 15,960 |
| Other current assets | 460 | 510 | 450 | 670 | 860 |
| TOTAL | $21,450 | $23,110 | $25,020 | $27,630 | $29,130 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | N/A | 4,806 |
| Other Non-Current Assets | 1,220 | 1,210 | 1,150 | 1,060 | 1,040 |
| TOTAL | $1,220 | $1,210 | $1,150 | $1,060 | $5,846 |
| Total Assets | $23,270 | $25,000 | $27,360 | $29,640 | $31,370 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 250 | 380 | 470 | 1,250 | 420 |
| Accrued Expenses | 870 | 950 | 970 | 1,250 | 960 |
| Other current liabilities | 2,270 | 1,900 | 2,100 | 1,270 | 2,290 |
| TOTAL | $3,420 | $3,280 | $3,620 | $3,920 | $3,870 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $8 | $20 |
| Total Liabilities | $3,420 | $3,280 | $3,620 | $3,930 | $3,900 |
| Shareholders' Equity | |||||
| Common Shares | 180 | 180 | 180 | 180 | 180 |
| Retained earnings | -60,750 | -58,820 | -56,730 | -54,740 | -52,870 |
| Other shareholders' equity | 0 | -10 | -20 | -30 | -70 |
| TOTAL | $19,850 | $21,710 | $23,740 | $25,710 | $27,460 |
| Total Liabilities And Equity | $23,270 | $24,990 | $27,360 | $29,640 | $31,360 |